comparemela.com
  1. Home
  2. Live Updates
  3. Loic Mourey - Breaking News

Latest Breaking News On - Loic mourey - Page 1 : comparemela.com

Abiraterone for De Novo mHSPC Less Beneficial at Age 70+

Men aged 70 years or older with de novo mHSPC derive less benefit from abiraterone plus prednisone added to standard of care.

United statesSan franciscoLoic moureyAmerican society of clinical oncologyAmerican societyClinical oncologyCancers symposiumLinstitut universitaire

ASCO GU 2023: Pembrolizumab plus Docetaxel for Patients with mCRPC: Randomized, Double-Blind, Phase 3 KEYNOTE-921 Study

ASCO GU 2023: Pembrolizumab plus Docetaxel for Patients with mCRPC: Randomized, Double-Blind, Phase 3 KEYNOTE-921 Study
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoAndrewj armstrongDaniel petrylakCharles schlossKarim fizaziErnesto pablo korbenfeldRustem gafanovPawel zalewskiHoward gurneyWinaldr gerritsenRussell kent pachynskiZachary klaassenNobuaki matsubaraGero kramerLoic mourey
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.